共 281 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2015)Emerging trends in hepatocellular carcinoma incidence and mortality Hepatology 61 191-199
[3]
Soerjomataram I(2010)Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection Aliment Pharmacol Ther 32 344-355
[4]
Siegel RL(2013)Epidemiology of hepatocellular carcinoma: consider the population J Clin Gastroenterol 47 S2-S6
[5]
Torre LA(2017)Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis J Carcinog 16 1-952
[6]
Jemal A(2005)Adaptive immune responses in acute and chronic hepatitis C virus infection Nature 436 946-1939
[7]
Njei B(2006)Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival J Natl Med Assoc 98 1934-52
[8]
Rotman Y(2016)Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States Hepatobiliary Surg Nutr 5 43-1163
[9]
Ditah I(2010)Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma Arch Surg 145 1158-2523
[10]
Lim JK(2016)Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States Cancer 122 2512-88